CELV OTC
Cellev8 Nutrition Inc.
1W: +59.0%
1M: +194.1%
3M: +260.0%
YTD: +71.4%
1Y: -0.7%
3Y: +260.0%
5Y: -34.5%
$0.18
+0.00 (+0.00%)
Weekly Expected Move ±59.7%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-32.1% ▼
Capital Expenditures
$4K
-73100.0% ▼
Free Cash Flow
-$2M
-32.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$251K
+326.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$573K | -$488K | -$725K | $264K | -$2M |
| Depreciation & Amort. | $4K | $6K | $5K | $4K | $34 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$13K | $9K | -$1K | -$2M | -$225K |
| Other Non-Cash Items | $21K | $1K | $885 | $763 | $1K |
| Operating Cash Flow | -$583K | -$472K | -$720K | -$1M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6K | -$680 | $0 | $0 | -$4K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$6K | -$680 | $0 | $0 | -$4K |
| — Financing Activities — | |||||
| Net Debt Issuance | $301K | -$3M | $5K | $172K | -$419K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $106K | -$2M | $91K | $69K | $2M |
| Financing Cash Flow | $606K | $487K | $799K | $1M | $2M |
| Net Change in Cash | $17K | $13K | $78K | $59K | $251K |
| Cash End of Period | $18K | $32K | $110K | $169K | $419K |
| Free Cash Flow | -$589K | -$473K | -$720K | -$1M | -$2M |